that is impossible. No way will BDTX go against the rules of ASCO. They are very specific and strict. They are doing the webcast, in my opinion, to get information out to shareholders so they can freely discuss this info with potential partners, They will only discuss the info on the abstract withhin the webcast otherwise they couldnt disclose much to them. The saturday event is where the updated info will be presented, never before. I think we will see a detailed 8k on saturday following the oral presentation. But i think we can easily see tomorrow if this is best in class or not. I am really counting on that they will explain why immature or a NR is the best news possible. This is why they got the oral, in my opinion. I hope you are right that they will talk about C797S as this is the white night to crazy valuation :) However, i feel this info comes only from the FDA meeting notes.
Market Data 
Markets 
AI
